Please use this identifier to cite or link to this item:
http://hdl.handle.net/10397/34960
Title: | Noninvasive detection of cancer-associated genome-wide hypomethylation and copy number aberrations by plasma DNA bisulfite sequencing | Authors: | Chan, KCA Jiang, P Chan, CWM Sun, K Wong, J Hui, EP Chan, SL Chan, WC Hui, DSC Ng, SSM Chan, HLY Wong, CSC Ma, BBY Chan, ATC Lai, PBS Sun, H Chiu, RWK Lo, YMD |
Keywords: | Epigenomics Epigenetics Next-generation sequencing Tumor markers Global hypomethylation |
Issue Date: | 2013 | Publisher: | National Academy of Sciences | Source: | Proceedings of the National Academy of Sciences of the United States of America, 2013, v. 110, no. 47, p. 18761-18768 How to cite? | Journal: | Proceedings of the National Academy of Sciences of the United States of America | Abstract: | We explored the detection of genome-wide hypomethylation in plasma using shotgun massively parallel bisulfite sequencing as a marker for cancer. Tumor-associated copy number aberrations (CNAs) could also be observed from the bisulfite DNA sequencing data. Hypomethylation and CNAs were detected in the plasma DNA of patients with hepatocellular carcinoma, breast cancer, lung cancer, nasopharyngeal cancer, smooth muscle sarcoma, and neuroendocrine tumor. For the detection of nonmetastatic cancer cases, plasma hypomethylation gave a sensitivity and specificity of 74% and 94%, respectively, when a mean of 93 million reads per case were obtained. Reducing the sequencing depth to 10 million reads per case was found to have no adverse effect on the sensitivity and specificity for cancer detection, giving respective figures of 68% and 94%. This characteristic thus indicates that analysis of plasma hypomethylation by this sequencing-based method may be a relatively cost-effective approach for cancer detection. We also demonstrated that plasma hypomethylation had utility for monitoring hepatocellular carcinoma patients following tumor resection and for detecting residual disease. Plasma hypomethylation can be combined with plasma CNA analysis for further enhancement of the detection sensitivity or specificity using different diagnostic algorithms. Using the detection of at least one type of aberration to define an abnormality, a sensitivity of 87% could be achieved with a specificity of 88%. These developments have thus expanded the applications of plasma DNA analysis for cancer detection and monitoring. | URI: | http://hdl.handle.net/10397/34960 | ISSN: | 0027-8424 | EISSN: | 1091-6490 | DOI: | 10.1073/pnas.1313995110 |
Appears in Collections: | Journal/Magazine Article |
Show full item record
SCOPUSTM
Citations
138
Last Week
4
4
Last month
Citations as of Feb 21, 2019
WEB OF SCIENCETM
Citations
124
Last Week
0
0
Last month
Citations as of Feb 23, 2019
Page view(s)
112
Last Week
3
3
Last month
Citations as of Feb 17, 2019

Google ScholarTM
Check
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.